Two left in running for Healthscope hospital properties
MELBOURNE: The sale of a $1.2bn portfolio of Healthscope hospital properties is understood ... read more
Neuren drug finally been cleared by FDA in USA
SYDNEY: Australia’s top performing health stock for 2022, Neuren, has gained clearance from ... read more
Ebos gets boost with inclusion in prestigious MSCI index
WELLINGTON: Ebos Group, Australasia’s largest distributor of healthcare and medical products, energised the ... read more
